| 256 | 4 | 32 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨避孕药短时应用结合微刺激方案在40岁以上高FSH患者体外受精-胚胎移植中的促排卵效果及周期结局。方法 回顾性分析2016年1月至2020年10月在南京医科大学第一附属医院生殖中心行克罗米芬联合HMG微刺激IVF或ICSI助孕的40岁以上患者的临床资料，共227个周期。其中，基础FSH≥20 U/L者予口服避孕药(OCP)短时预处理，为OCP组(n=103);而10 U/L
Objective:To investigate the effect and outcome of short-term application of contraceptives combined with micro stimulation protocol during IVF-ET in patients over 40 years old with high FSH.Methods:The clinical data of patients(227 cycles) aged >40 years who underwent IVF/ICSI with clomiphene and micro stimulation protocol in of Reproductive Medicine Center, the First Affiliated Hospital of Nanjing Medical University from January 2016 to October 2020 were retrospectively analyzed. Among them, the patients with basal FSH≥20 U/L had short-term pretreatment with oral contraceptive(OCP) as OCP group(n=103),and the patients with 10 U/L
[1] Reed BG,Babayev SN,Bukulmez O.Shifting paradigms in diminished ovarian reserve and advanced reproductive age in assisted reproduction:customization instead of conformity[J].Semin Reprod Med,2015,33:169-178.
[2] Devine K,Mumford SL,Wu M,et al,Diminished ovarian reserve in the United States assisted reproductive technology population:diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System[J].Fertil Steril,2015,104:612-619.
[3] 郭晓婕，张竑.南京城市职业女性二胎生育意愿调查及影响因素分析[J].中国计划生育学杂志，2021,29:661-666.
[4] Scott RT,Toner JP,Muasher SJ,et al,Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome[J].Fertil Steril,1989,51:651-654.
[5] Alper MM,Jolly EE,Garner PR.Pregnancies after premature ovarian failure[J].Obstet Gynecol,1986,67(suppl 3):s59-62.
[6] Check JH,Katsoff B,Brasile D,et al.Pregnancy outcome following in vitro fertilization-embryo transfer(IVF-ET)in women of more advanced reproductive age with elevated serum follicle stimulating hormone(FSH)levels[J].Clin Exp Obstet Gynecol,2008,35:13-15.
[7] Wei D,Shi Y,Li J,et al.Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome[J].Hum Reprod,2017,32:354-361.
[8] 夏梦，董娟，马龙，等.40岁以上高龄女性体外受精-胚胎移植妊娠结局分析[J].国际生殖健康/计划生育杂志，2019,38:269-275.
[9] Vural B,Cakiroglu Y,Vural F,et al,Hormonal and functional biomarkers in ovarian response[J].Arch Gynecol Obstet,2014,289:1355-1361.
[10] Li S,Hu L,Zhang C.Effect of chronological age of patients with diminished ovarian reserve on in vitro fertilization outcome [J].J Obstet Gynaecol,2021,2021:1-4.
[11] Roberts JE,Spandorfer S,Fasouliotis SJ,et al.Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization[J].Fertil Steril,2005,83:37-41.
[12] Burks HR,Baker M,Quaas AM,et al.The dilemma of counseling patients about poor prognosis:live birth after IVF with autologous oocytes in a 43-year-old woman with FSH levels above 30 mIU/mL[J].J Assist Reprod Genet,2017,34:1185-1188.
[13] Welch M 3rd.Oocyte donation:an assisted reproductive technique[J].Curr Surg,2004,61:563-564.
[14] 谢宝国，卢伟英.辅助生殖技术供卵法规合理性的伦理学思考[J].医学与哲学，2018,39:26-27.
[15] Xu H,Deng K,Luo Q,et al.High serum FSH is associated with brown oocyte formation and a lower pregnacy rate in human IVF parctice[J].Cell Physiol Biochem,2016,39:677-684.
[16] Gingold JA,Lee JA,Whitehouse MC,et al.Maximum basal FSH predicts reproductive outcome better than cycle-specific basal FSH levels:waiting for a “better” month conveys limited retrieval benefits[J].Reprod Biol Endocrinol,2015,13:91.
[17] Ben-Nagi J,Panay N.Premature ovarian insufficiency:how to improve reproductive outcome?[J].Climacteric,2014,17:242-246.
[18] Check JH,Chase JS,Spence M.Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy[J].Am J Obstet Gynecol,1989,160:114-115.
[19] Neves-E-Castro M.Effects of oral contraceptives on ovulation induction[J].Climacteric,2018,21:617.
[20] Brahma PK,Kallen CB.Ovarian hyperstimulation after a short course of an oral contraceptive in a patient with premature ovarian failure[J].Fertil Steril,2008,90:2004.e15-e17.
[21] 李妍，张少娣，王雪，等.避孕药在不同年龄高卵泡刺激素患者体外受精-胚胎移植中的短时应用分析[J].中国实用医刊，2018,45:1-5.
[22] 赵冬梅，曲庆兰，郝翠芳.妈富隆在高FSH患者IVF-ET中的短期应用分析：附2例病例报告[J].生殖医学杂志，2017,26:614-616.
[23] 杨弘睚，马媛，石永乾，等.不同控制性卵巢刺激方案对早发性卵巢功能不全患者获卵数和可用胚胎数的影响[J].生殖医学杂志，2020,29:1280-1286.
[24] 杜晓果，杨蕊，陈新娜，等.口服避孕药预处理时间对预期卵巢低反应患者临床结局的影响[J].生殖医学杂志，2020,29:162-168.
[25] Check ML,Check JH,Wilson C,et al.Outcome of in vitro fertilization-embryo transfer according to age in poor responders with elevated baseline serum follicle stimulation hormone using minimal or no gonadotropin stimulation[J].Clin Exp Obstet Gynecol,2004,31:183-184.
[26] Tartagni M,Cicinelli E,Pergola GD,et al.Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure:a randomized,placebo-controlled trial[J].Fertil Steril,2007,87:858-861.
基本信息:
中图分类号:R714.8
引用信息:
[1]蒋春艳,鲁南,张园,等.短效口服避孕药在40岁以上高FSH患者IVF/ICSI中的短时应用分析[J].生殖医学杂志,2022,31(04):435-440.
基金信息:
江苏省高校优势学科建设工程(JX10231802); 国家自然科学基金(81501225); 江苏省自然科学基金(BK20151030); 江苏省卫健委项目(M2020097)
2022-04-15
2022-04-15